Elkalmi Ramadan M, Elnaem Mohamed Hassan, Sapar Nurmisaliza Mohd, Blebil Ali
Department of Pharmacology, Faculty of Medicine, Sebha University, Sabha, Libya.
Department of Pharmacy Practice, Kulliyyah of Pharmacy, International Islamic University Malaysia.
J Pharm Bioallied Sci. 2021 Jul-Sep;13(3):325-330. doi: 10.4103/jpbs.JPBS_577_20. Epub 2021 Nov 24.
This study aimed to assess the completeness and quality of adverse drug reaction (ADR) reports that were submitted to the Pharmacovigilance Unit (PVU) in clinical training center (CTC), Faculty of Medicine, UiTM Sungai Buloh Campus.
A retrospective study was conducted using all ADR reports that were submitted to the PVU in CTC from December 31, 2000, to December 31, 2018. The completeness was assessed by reviewing all the required elements to be filled in the ADR reports. The quality was assessed by investigating the required information in the ADR reporting form. Descriptive statistics have been used to present the findings.
In a total of 31 reports that were submitted to the PVU in CTC, 98.9% of patient's information and 100% of ADR descriptions were completed. Suspected drug information and the reporter's details were completed by 52.2% and 79.6%, respectively. Of 58.0% of the information about seriousness recorded, 38.9% ( = 7) is mild, 44.4% ( = 8) is moderate, and 16.7% ( = 3) is severe. Among all the suspected medicines, drug class of antibiotics (32.4%, = 12) is the most reported suspected drugs that caused ADR, followed by opioid analgesic (8.1%, = 3) and nonsteroidal anti-inflammatory drugs (8.1%, = 3).
Further efforts and relevant interventions should be considered to increase the reporting frequency and to enhance the completeness and the quality of the ADR reports in the study setting.
本研究旨在评估提交至马来西亚理科大学双溪毛糯校区医学院临床培训中心药物警戒部门(PVU)的药品不良反应(ADR)报告的完整性和质量。
采用回顾性研究方法,分析2000年12月31日至2018年12月31日期间提交至临床培训中心药物警戒部门的所有ADR报告。通过审查ADR报告中所有必填项目来评估完整性。通过调查ADR报告表中的所需信息来评估质量。使用描述性统计方法呈现研究结果。
在提交至临床培训中心药物警戒部门的31份报告中,98.9%的患者信息和100%的ADR描述填写完整。可疑药物信息和报告者详细信息的填写率分别为52.2%和79.6%。在记录的严重性信息中,58.0%为轻度(38.9%,即7例),44.4%为中度(44.4%,即8例),16.7%为重度(16.7%,即3例)。在所有可疑药物中,抗生素类药物(32.4%,即12例)是报告最多的引起ADR的可疑药物,其次是阿片类镇痛药(8.1%,即3例)和非甾体抗炎药(8.1%,即3例)。
应考虑进一步努力并采取相关干预措施,以提高研究环境中ADR报告的上报频率,增强报告的完整性和质量。